Anticoagulation Forum

Anticoagulation Forum TRAIN Pharmacist Grant

Four AC Forum TRAIN Pharmacist Residency Grants Awarded!
Anticoagulation Forum is pleased to announce that 4 sites have been selected to receive 2 years of funding for pharmacist PGY2 residencies in Thrombosis and Hemostasis Management for the 2023-24 and 2024-25 residency cycles. The successful applicants are: Henry Ford Health (Detroit, MI), Johns Hopkins Health (Baltimore, MD), Sanford Health (Sioux Falls, SD) and the University of New Mexico (Albuquerque, NM). The application and award cycle will open again in Spring 2023. For more information on these residency sites and the TRAIN Pharmacist Grant Program visit the program website and visit the AC Forum booth in the Residency Showcase at the ASHP Midyear Clinical Meeting on the afternoon of Tuesday, December 6th in Las Vegas.

This recently established 1-year residency, authorized by ASHP, will increase the number of expert clinicians equipped to effectively manage patients at risk for thrombosis and bleeding, and support the creation of anticoagulation stewardship programs nationwide.

Grant Award
The award payment offers each institution $120,000 over a 2-year period. The goal of this grant is to support the institution in developing the new program, as well as provide salary assistance for two consecutive residency years.

The AC Forum will award up four 2-year grants in 2022 and 4 additional 2-year grants in 2023.

Application Dates
Applications for the 2023-24 Residency Program are now closed. The application for the 2024-25 cycle will open in spring of 2023.

For more information visit:

Advancing Anticoagulation Stewardship: A Playbook

AC Forum is proud to announce in collaboration with the National Quality Forum, the publishing of Advancing Anticoagulation Stewardship: A Playbook.

This Playbook centers on the Anticoagulation Forum’s Core Elements of Anticoagulation Stewardship and offers concrete strategies and implementation examples for healthcare organizations and clinicians who wish to create, promote, and sustain an Anticoagulation Stewardship program.

Visit the NQF Store to download a free copy.

FDA-funded Anticoagulation Stewardship Guide

Download our new FDA-funded release, Core Elements of the Anticoagulation Stewardship Program, which outlines systemic protocols designed  to improve the safety  and quality of care for patients and reduce the adverse drug effects related to anticoagulant medications. 

IDEA Initiative

The Inclusion, Diversity, Equity, and Allyship (IDEA) Initiative was established to address systemic racism and the resulting health disparities. Through this Initiative, the AC Forum will work to increase awareness and promote diversity in our leadership, membership, and programming.

Our initiatives include a webinar series, educational tools and resources, as well as scholarships to our conference and Boot Camp programs.

Learn More About Health Disparities and the IDEA Initiative.

Featured Webinar: Understanding the Social Determinants of Health
Join members of the AC Forum IDEA Initiative as they discuss how an understanding of the social determinants of health can inform how practitioners engage with patients and introduce a new AC Forum Rapid Resource on this important topic.

Could I Have Stopped a Stroke
In this quick highlight video, learn how health disparities impact a patient’s access to quality health care and anticoagulation therapy.

Rapid Resource: Social Determinants of Health & Patient Care
This resource provides a brief overview the social determinants of health and highlights actions practitioners can incorporate into their practice to address health disparities.

Managing Anticoagulation During the COVID-19 Pandemic

Updated Guidance Published!

Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
May 2022 issue of the Journal of Thrombosis and Thrombolysis

AC Forum will continue to offer guidance on how best to protect your patients and staff while providing anticoagulation management during the current pandemic. Check back often for new updates!

News & Announcements:

Direct Oral Anticoagulants vs Vitamin-K Antagonists in Thrombotic Antiphospholipid Syndrome: Meta-analysis of Randomized Controlled Trials

Don’t miss our upcoming webinar on January 30, 2022 @ 12:00 PM ET!

The efficacy and safety of direct oral anticoagulants (DOACs) for patients with thrombotic antiphospholipid syndrome (APS) remain controversial. In this webinar, we discuss the results of a recent study on DOACs vs Vitamin-K Antagonists (VKAs) in Thrombotic APS which found that patients with thrombotic APS randomized to DOACs appear to have increased risk for arterial thrombosis when compared to VKAs. We will also highlight a recently published AC Forum Rapid Resource on Antiphospholipid Syndrome.

Guest Faculty:
Behnood Bikdeli, MD, MS
Jean Connors, MD
Surabhi Palkimas, PharmD

Geoff Barnes, MD, MSc
Deborah Siegal, MD, MSc, FRCPC

ASHP Podcast: VTE Prophylaxis in the Medically Ill: Extending the Conversation, Part 3

In this podcast clip, AC Forum President Dr. Allison Burnett highlights the importance of anticoagulation stewardship, a key step in moving the needle on improving the safe and effective use of anticoagulants.

Listen to the full Podcast.  

Practitioner's Guide for Improving Oral Anticoagulant Use, Online CE from the FDA (CE), June 2020

Free 1-hour course from the FDA on all the fundamental aspects of oral anticoagulation management including overviews of disease state & risk assessment, warfarin, DOACs, DDIs and patient issues such as compliance & joint decision-making; slides and transcript available for download; 1 hour of continuing education credit is available for physicians, nurses & pharmacists until 6/1/23.

View Course Here  


Literature Update

Curated & searchable literature database by topic, updated every two weeks.

View Literature Update

Upcoming Events

Follow Us On Twitter

Sponsored by: